Symbol:
Nbl1
Name:
NBL1, DAN family BMP antagonist
RGD ID:
3151
Description:
Predicted to enable BMP binding activity; identical protein binding activity; and morphogen activity. Predicted to be involved in several processes, including determination of dorsal identity; negative regulation of BMP signaling pathway; and negative regulation of monocyte chemotaxis. Predicted to act upstream of or within neuron projection morphogenesis and positive regulation of neuron differentiation. Predicted to be located in extracellular region and membrane. Predicted to be active in extracellular space. Orthologous to several human genes including NBL1 (NBL1, DAN family BMP antagonist); INTERACTS WITH 2,3,7,8-tetrachlorodibenzodioxine; 4,4'-sulfonyldiphenol; 6-propyl-2-thiouracil.
Type:
protein-coding
RefSeq Status:
PROVISIONAL
Previously known as:
N03; neuroblastoma 1; neuroblastoma 1, DAN family BMP antagonist; neuroblastoma suppression of tumorigenicity 1; Neuroblastoma suppression of tumorigenicity 1 (DNA segment human D1S1733E); neuroblastoma suppressor of tumorigenicity 1; neuroblastoma, suppression of tumorigenicity 1; Neuroblastoma, suppression of tumorigenicity 1 (DNA segment human D1S1733E); zinc finger protein DAN
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Homo sapiens (human):
NBL1 (NBL1, DAN family BMP antagonist)
HGNC
EggNOG, Ensembl, HomoloGene, Inparanoid, OMA, Panther
Mus musculus (house mouse):
Nbl1 (NBL1, DAN family BMP antagonist)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chinchilla lanigera (long-tailed chinchilla):
Nbl1 (NBL1, DAN family BMP antagonist)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Pan paniscus (bonobo/pygmy chimpanzee):
NBL1 (NBL1, DAN family BMP antagonist)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Canis lupus familiaris (dog):
NBL1 (NBL1, DAN family BMP antagonist)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Nbl1 (NBL1, DAN family BMP antagonist)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Sus scrofa (pig):
NBL1 (NBL1, DAN family BMP antagonist)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chlorocebus sabaeus (green monkey):
NBL1 (NBL1, DAN family BMP antagonist)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Heterocephalus glaber (naked mole-rat):
Nbl1 (NBL1, DAN family BMP antagonist)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Other homologs 2
Homo sapiens (human):
MICOS10-NBL1 (MICOS10-NBL1 readthrough)
HGNC
HomoloGene
Homo sapiens (human):
ZNF526 (zinc finger protein 526)
HGNC
OMA
Alliance orthologs 3
Homo sapiens (human):
NBL1 (NBL1, DAN family BMP antagonist)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Mus musculus (house mouse):
Nbl1 (NBL1, DAN family BMP antagonist)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Homo sapiens (human):
MICOS10-NBL1 (MICOS10-NBL1 readthrough)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Danio rerio (zebrafish):
nbl1 (NBL1, DAN family BMP antagonist)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Xenopus tropicalis (tropical clawed frog):
nbl1
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 5 156,601,986 - 156,613,182 (-) NCBI GRCr8 mRatBN7.2 5 151,318,752 - 151,329,948 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 5 151,318,754 - 151,338,719 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 5 154,015,980 - 154,027,177 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 5 155,790,290 - 155,801,487 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 5 155,772,293 - 155,783,465 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 5 157,524,569 - 157,535,701 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 5 157,524,513 - 157,535,664 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 5 161,263,765 - 161,274,897 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 Celera 5 149,703,598 - 149,714,771 (-) NCBI Celera Cytogenetic Map 5 q36 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Nbl1 Rat 14-Deoxy-11,12-didehydroandrographolide decreases expression ISO NBL1 (Homo sapiens) 6480464 14-deoxy-11 and 12-didehydroandrographolide results in decreased expression of NBL1 mRNA CTD PMID:22101062 Nbl1 Rat 17beta-estradiol increases expression ISO Nbl1 (Mus musculus) 6480464 Estradiol results in increased expression of NBL1 mRNA CTD PMID:19484750 Nbl1 Rat 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO NBL1 (Homo sapiens) 6480464 Dihydrotestosterone results in increased expression of NBL1 mRNA CTD PMID:29581250 Nbl1 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO NBL1 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in increased expression of NBL1 mRNA CTD PMID:20106945 and PMID:21632981 Nbl1 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of NBL1 mRNA CTD PMID:34747641 Nbl1 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Nbl1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of NBL1 mRNA CTD PMID:26377647 Nbl1 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Nbl1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of NBL1 mRNA CTD PMID:19933214 Nbl1 Rat 2,4-dibromophenyl 2,4,5-tribromophenyl ether affects expression ISO Nbl1 (Mus musculus) 6480464 2 more ... CTD PMID:38648751 Nbl1 Rat 2-methylcholine affects expression ISO NBL1 (Homo sapiens) 6480464 beta-methylcholine affects the expression of NBL1 mRNA CTD PMID:21179406 Nbl1 Rat 4,4'-sulfonyldiphenol increases expression ISO Nbl1 (Mus musculus) 6480464 bisphenol S results in increased expression of NBL1 mRNA CTD PMID:30951980 Nbl1 Rat 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of NBL1 mRNA CTD PMID:36041667 Nbl1 Rat 4,4'-sulfonyldiphenol increases methylation ISO Nbl1 (Mus musculus) 6480464 bisphenol S results in increased methylation of NBL1 promoter CTD PMID:33297965 Nbl1 Rat 4-hydroxyphenyl retinamide decreases expression ISO Nbl1 (Mus musculus) 6480464 Fenretinide results in decreased expression of NBL1 mRNA CTD PMID:16467112 Nbl1 Rat 5-fluorouracil decreases expression ISO NBL1 (Homo sapiens) 6480464 Fluorouracil results in decreased expression of NBL1 mRNA CTD PMID:16709241 Nbl1 Rat 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of NBL1 mRNA CTD PMID:24780913 and PMID:30047161 Nbl1 Rat acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of NBL1 mRNA CTD PMID:28959563 Nbl1 Rat acrylamide increases expression ISO NBL1 (Homo sapiens) 6480464 Acrylamide results in increased expression of NBL1 mRNA CTD PMID:32763439 Nbl1 Rat aflatoxin B1 increases expression ISO NBL1 (Homo sapiens) 6480464 Aflatoxin B1 results in increased expression of NBL1 mRNA CTD PMID:22100608 Nbl1 Rat aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of NBL1 mRNA CTD PMID:33354967 Nbl1 Rat all-trans-retinoic acid increases expression ISO NBL1 (Homo sapiens) 6480464 Tretinoin results in increased expression of NBL1 mRNA CTD PMID:17431108 Nbl1 Rat alpha-Zearalanol multiple interactions EXP 6480464 [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of NBL1 mRNA CTD PMID:35163327 Nbl1 Rat amitrole decreases expression EXP 6480464 Amitrole results in decreased expression of NBL1 mRNA CTD PMID:30047161 Nbl1 Rat ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of NBL1 mRNA CTD PMID:16483693 Nbl1 Rat amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of NBL1 mRNA CTD PMID:30779732 Nbl1 Rat Aroclor 1254 increases expression ISO Nbl1 (Mus musculus) 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of NBL1 mRNA CTD PMID:23650126 Nbl1 Rat arsane affects expression ISO NBL1 (Homo sapiens) 6480464 Arsenic affects the expression of NBL1 protein CTD PMID:24675094 Nbl1 Rat arsenic atom affects expression ISO NBL1 (Homo sapiens) 6480464 Arsenic affects the expression of NBL1 protein CTD PMID:24675094 Nbl1 Rat atrazine increases expression ISO NBL1 (Homo sapiens) 6480464 Atrazine results in increased expression of NBL1 mRNA CTD PMID:22378314 Nbl1 Rat benzo[a]pyrene increases methylation ISO NBL1 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of NBL1 promoter CTD PMID:27901495 Nbl1 Rat benzo[a]pyrene increases expression ISO NBL1 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of NBL1 mRNA CTD PMID:32234424 Nbl1 Rat benzo[a]pyrene decreases expression ISO Nbl1 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of NBL1 mRNA CTD PMID:32417428 Nbl1 Rat bis(2-ethylhexyl) phthalate increases expression ISO Nbl1 (Mus musculus) 6480464 Diethylhexyl Phthalate results in increased expression of NBL1 mRNA CTD PMID:33754040 Nbl1 Rat bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of NBL1 mRNA CTD PMID:25181051 Nbl1 Rat bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of NBL1 mRNA CTD PMID:36041667 Nbl1 Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of NBL1 mRNA CTD PMID:32145629 and PMID:38750585 Nbl1 Rat bisphenol A increases expression ISO Nbl1 (Mus musculus) 6480464 bisphenol A results in increased expression of NBL1 mRNA CTD PMID:30951980 and PMID:32156529 Nbl1 Rat bisphenol F increases expression ISO Nbl1 (Mus musculus) 6480464 bisphenol F results in increased expression of NBL1 mRNA CTD PMID:30951980 Nbl1 Rat bisphenol F multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of NBL1 mRNA CTD PMID:36041667 Nbl1 Rat cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of NBL1 mRNA CTD PMID:21297351 Nbl1 Rat cadmium dichloride increases expression ISO NBL1 (Homo sapiens) 6480464 Cadmium Chloride results in increased expression of NBL1 mRNA CTD PMID:38568856 Nbl1 Rat cadmium dichloride increases methylation EXP 6480464 Cadmium Chloride results in increased methylation of NBL1 promoter CTD PMID:22457795 Nbl1 Rat calcitriol increases expression ISO NBL1 (Homo sapiens) 6480464 Calcitriol results in increased expression of NBL1 mRNA CTD PMID:21592394 Nbl1 Rat calcitriol multiple interactions ISO NBL1 (Homo sapiens) 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of NBL1 mRNA CTD PMID:21592394 Nbl1 Rat carbamazepine affects expression ISO NBL1 (Homo sapiens) 6480464 Carbamazepine affects the expression of NBL1 mRNA CTD PMID:25979313 Nbl1 Rat carbon nanotube decreases expression ISO Nbl1 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 Nbl1 Rat carmustine affects response to substance ISO NBL1 (Homo sapiens) 6480464 NBL1 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 Nbl1 Rat choline multiple interactions ISO Nbl1 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of NBL1 gene CTD PMID:20938992 Nbl1 Rat chromium(6+) increases expression ISO NBL1 (Homo sapiens) 6480464 chromium hexavalent ion results in increased expression of NBL1 protein CTD PMID:28596144 Nbl1 Rat cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of NBL1 mRNA CTD PMID:22023808 Nbl1 Rat cisplatin multiple interactions ISO NBL1 (Homo sapiens) 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of NBL1 mRNA CTD PMID:27392435 Nbl1 Rat cobalt dichloride decreases expression ISO NBL1 (Homo sapiens) 6480464 cobaltous chloride results in decreased expression of NBL1 mRNA CTD PMID:19376846 Nbl1 Rat copper(II) chloride increases expression ISO NBL1 (Homo sapiens) 6480464 cupric chloride results in increased expression of NBL1 mRNA CTD PMID:38568856 Nbl1 Rat DDE decreases expression ISO NBL1 (Homo sapiens) 6480464 Dichlorodiphenyl Dichloroethylene results in decreased expression of NBL1 mRNA CTD PMID:38568856 Nbl1 Rat dexamethasone decreases expression EXP 6480464 Dexamethasone results in decreased expression of NBL1 mRNA CTD PMID:20032058 Nbl1 Rat dexamethasone multiple interactions EXP 6480464 Testosterone inhibits the reaction [Dexamethasone results in decreased expression of NBL1 mRNA] CTD PMID:20032058 Nbl1 Rat diazinon increases methylation ISO NBL1 (Homo sapiens) 6480464 Diazinon results in increased methylation of NBL1 gene CTD PMID:22964155 Nbl1 Rat dibutyl phthalate increases expression ISO Nbl1 (Mus musculus) 6480464 Dibutyl Phthalate results in increased expression of NBL1 mRNA CTD PMID:21266533 Nbl1 Rat dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of NBL1 mRNA CTD PMID:21266533 Nbl1 Rat dimethylarsinic acid increases expression EXP 6480464 Cacodylic Acid results in increased expression of NBL1 mRNA CTD PMID:16122865 Nbl1 Rat diuron decreases expression EXP 6480464 Diuron results in decreased expression of NBL1 mRNA CTD PMID:21551480 and PMID:25152437 Nbl1 Rat dorsomorphin multiple interactions ISO NBL1 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NBL1 mRNA CTD PMID:27188386 Nbl1 Rat doxorubicin decreases expression ISO NBL1 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of NBL1 mRNA CTD PMID:29803840 Nbl1 Rat endosulfan affects expression EXP 6480464 Endosulfan affects the expression of NBL1 mRNA CTD PMID:29391264 Nbl1 Rat entinostat increases expression ISO NBL1 (Homo sapiens) 6480464 entinostat results in increased expression of NBL1 mRNA CTD PMID:27188386 Nbl1 Rat folic acid multiple interactions ISO Nbl1 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of NBL1 gene CTD PMID:20938992 Nbl1 Rat furan increases expression EXP 6480464 furan results in increased expression of NBL1 mRNA CTD PMID:27387713 Nbl1 Rat gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of NBL1 mRNA CTD PMID:33387578 Nbl1 Rat glycine betaine increases expression EXP 6480464 Betaine results in increased expression of NBL1 mRNA CTD PMID:26391144 Nbl1 Rat L-methionine multiple interactions ISO Nbl1 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of NBL1 gene CTD PMID:20938992 Nbl1 Rat lead diacetate increases expression ISO NBL1 (Homo sapiens) 6480464 lead acetate results in increased expression of NBL1 mRNA CTD PMID:38568856 Nbl1 Rat lead(0) affects expression ISO NBL1 (Homo sapiens) 6480464 Lead affects the expression of NBL1 mRNA CTD PMID:28903495 Nbl1 Rat methimazole decreases expression EXP 6480464 Methimazole results in decreased expression of NBL1 mRNA CTD PMID:30047161 Nbl1 Rat methotrexate decreases expression ISO NBL1 (Homo sapiens) 6480464 Methotrexate results in decreased expression of NBL1 mRNA CTD PMID:17400583 Nbl1 Rat methylmercury chloride increases expression ISO NBL1 (Homo sapiens) 6480464 methylmercuric chloride results in increased expression of NBL1 mRNA CTD PMID:28001369 Nbl1 Rat methylparaben increases expression ISO NBL1 (Homo sapiens) 6480464 methylparaben results in increased expression of NBL1 mRNA CTD PMID:38568856 Nbl1 Rat N-methyl-N'-nitro-N-nitrosoguanidine decreases expression ISO NBL1 (Homo sapiens) 6480464 Methylnitronitrosoguanidine results in decreased expression of NBL1 mRNA CTD PMID:12634122 Nbl1 Rat nitrofen decreases expression EXP 6480464 nitrofen results in decreased expression of NBL1 mRNA CTD PMID:26720608 Nbl1 Rat O-methyleugenol increases expression ISO NBL1 (Homo sapiens) 6480464 methyleugenol results in increased expression of NBL1 mRNA CTD PMID:32234424 Nbl1 Rat oxybenzone decreases expression ISO Nbl1 (Mus musculus) 6480464 oxybenzone results in decreased expression of NBL1 mRNA CTD PMID:39343157 Nbl1 Rat oxybenzone increases expression ISO Nbl1 (Mus musculus) 6480464 oxybenzone results in increased expression of NBL1 mRNA CTD PMID:39343157 Nbl1 Rat paracetamol increases expression ISO NBL1 (Homo sapiens) 6480464 Acetaminophen results in increased expression of NBL1 mRNA CTD PMID:22230336 Nbl1 Rat paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of NBL1 mRNA CTD PMID:33387578 Nbl1 Rat perfluorohexanesulfonic acid increases expression ISO Nbl1 (Mus musculus) 6480464 perfluorohexanesulfonic acid results in increased expression of NBL1 mRNA CTD PMID:37995155 Nbl1 Rat perfluorononanoic acid decreases expression ISO NBL1 (Homo sapiens) 6480464 perfluoro-n-nonanoic acid results in decreased expression of NBL1 mRNA CTD PMID:38568856 Nbl1 Rat perfluorooctanoic acid multiple interactions EXP 6480464 [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of NBL1 mRNA CTD PMID:35163327 Nbl1 Rat propylparaben increases expression ISO NBL1 (Homo sapiens) 6480464 propylparaben results in increased expression of NBL1 mRNA CTD PMID:38568856 Nbl1 Rat raloxifene increases expression EXP 6480464 Raloxifene Hydrochloride results in increased expression of NBL1 mRNA CTD PMID:15576828 Nbl1 Rat SB 431542 multiple interactions ISO NBL1 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NBL1 mRNA CTD PMID:27188386 Nbl1 Rat silver atom decreases expression ISO Nbl1 (Mus musculus) 6480464 Silver results in decreased expression of NBL1 mRNA CTD PMID:27131904 Nbl1 Rat silver(0) decreases expression ISO Nbl1 (Mus musculus) 6480464 Silver results in decreased expression of NBL1 mRNA CTD PMID:27131904 Nbl1 Rat sodium arsenite increases expression ISO NBL1 (Homo sapiens) 6480464 sodium arsenite results in increased expression of NBL1 mRNA CTD PMID:38568856 Nbl1 Rat sodium arsenite decreases expression ISO Nbl1 (Mus musculus) 6480464 sodium arsenite results in decreased expression of NBL1 mRNA CTD PMID:36209798 and PMID:37682722 Nbl1 Rat sulfadimethoxine decreases expression EXP 6480464 Sulfadimethoxine results in decreased expression of NBL1 mRNA CTD PMID:30047161 Nbl1 Rat temozolomide affects response to substance ISO NBL1 (Homo sapiens) 6480464 NBL1 mRNA affects the susceptibility to temozolomide CTD PMID:16365179 Nbl1 Rat temozolomide increases expression ISO NBL1 (Homo sapiens) 6480464 Temozolomide results in increased expression of NBL1 mRNA CTD PMID:31758290 Nbl1 Rat testosterone increases expression ISO NBL1 (Homo sapiens) 6480464 Testosterone results in increased expression of NBL1 mRNA CTD PMID:21592394 Nbl1 Rat testosterone increases expression ISO Nbl1 (Mus musculus) 6480464 Testosterone deficiency results in increased expression of NBL1 mRNA CTD PMID:33848595 Nbl1 Rat testosterone multiple interactions ISO NBL1 (Homo sapiens) 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of NBL1 mRNA CTD PMID:21592394 Nbl1 Rat testosterone multiple interactions EXP 6480464 Testosterone inhibits the reaction [Dexamethasone results in decreased expression of NBL1 mRNA] CTD PMID:20032058 Nbl1 Rat thiram increases expression ISO NBL1 (Homo sapiens) 6480464 Thiram results in increased expression of NBL1 mRNA CTD PMID:38568856 Nbl1 Rat titanium dioxide decreases methylation ISO Nbl1 (Mus musculus) 6480464 titanium dioxide results in decreased methylation of NBL1 promoter CTD PMID:35295148 Nbl1 Rat trichloroethene increases expression ISO Nbl1 (Mus musculus) 6480464 Trichloroethylene results in increased expression of NBL1 mRNA CTD PMID:15363585 Nbl1 Rat trichostatin A decreases expression ISO NBL1 (Homo sapiens) 6480464 trichostatin A results in decreased expression of NBL1 mRNA CTD PMID:24935251 Nbl1 Rat valproic acid affects expression ISO Nbl1 (Mus musculus) 6480464 Valproic Acid affects the expression of NBL1 mRNA CTD PMID:17963808 Nbl1 Rat valproic acid multiple interactions ISO NBL1 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NBL1 mRNA CTD PMID:27188386 Nbl1 Rat valproic acid decreases expression ISO NBL1 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of NBL1 mRNA CTD PMID:23179753 and PMID:26272509 Nbl1 Rat valproic acid increases methylation ISO NBL1 (Homo sapiens) 6480464 Valproic Acid results in increased methylation of NBL1 gene CTD PMID:29154799 Nbl1 Rat valproic acid increases expression ISO NBL1 (Homo sapiens) 6480464 Valproic Acid results in increased expression of NBL1 mRNA CTD PMID:23179753 Nbl1 Rat valproic acid affects expression ISO NBL1 (Homo sapiens) 6480464 Valproic Acid affects the expression of NBL1 mRNA CTD PMID:25979313 Nbl1 Rat vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of NBL1 mRNA CTD PMID:23034163
14-Deoxy-11,12-didehydroandrographolide (ISO) 17beta-estradiol (ISO) 17beta-hydroxy-5alpha-androstan-3-one (ISO) 2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO) 2,4-dibromophenyl 2,4,5-tribromophenyl ether (ISO) 2-methylcholine (ISO) 4,4'-sulfonyldiphenol (EXP,ISO) 4-hydroxyphenyl retinamide (ISO) 5-fluorouracil (ISO) 6-propyl-2-thiouracil (EXP) acrylamide (EXP,ISO) aflatoxin B1 (EXP,ISO) all-trans-retinoic acid (ISO) alpha-Zearalanol (EXP) amitrole (EXP) ammonium chloride (EXP) amphetamine (EXP) Aroclor 1254 (ISO) arsane (ISO) arsenic atom (ISO) atrazine (ISO) benzo[a]pyrene (ISO) bis(2-ethylhexyl) phthalate (ISO) bisphenol A (EXP,ISO) bisphenol F (EXP,ISO) cadmium dichloride (EXP,ISO) calcitriol (ISO) carbamazepine (ISO) carbon nanotube (ISO) carmustine (ISO) choline (ISO) chromium(6+) (ISO) cisplatin (EXP,ISO) cobalt dichloride (ISO) copper(II) chloride (ISO) DDE (ISO) dexamethasone (EXP) diazinon (ISO) dibutyl phthalate (EXP,ISO) dimethylarsinic acid (EXP) diuron (EXP) dorsomorphin (ISO) doxorubicin (ISO) endosulfan (EXP) entinostat (ISO) folic acid (ISO) furan (EXP) gentamycin (EXP) glycine betaine (EXP) L-methionine (ISO) lead diacetate (ISO) lead(0) (ISO) methimazole (EXP) methotrexate (ISO) methylmercury chloride (ISO) methylparaben (ISO) N-methyl-N'-nitro-N-nitrosoguanidine (ISO) nitrofen (EXP) O-methyleugenol (ISO) oxybenzone (ISO) paracetamol (EXP,ISO) perfluorohexanesulfonic acid (ISO) perfluorononanoic acid (ISO) perfluorooctanoic acid (EXP) propylparaben (ISO) raloxifene (EXP) SB 431542 (ISO) silver atom (ISO) silver(0) (ISO) sodium arsenite (ISO) sulfadimethoxine (EXP) temozolomide (ISO) testosterone (EXP,ISO) thiram (ISO) titanium dioxide (ISO) trichloroethene (ISO) trichostatin A (ISO) valproic acid (ISO) vinclozolin (EXP)
Biological Process
determination of dorsal identity (IEA,ISO) negative regulation of BMP signaling pathway (IEA,ISO,ISS) negative regulation of monocyte chemotaxis (IEA,ISO) nervous system development (IEA,ISO) neuron differentiation (IEA,ISO) neuron projection morphogenesis (IEA,ISO) positive regulation of neuron differentiation (IEA,ISO) sequestering of BMP from receptor via BMP binding (IBA,IEA,ISO) sequestering of BMP in extracellular matrix (IEA,ISO) signal transduction (IEA)
Nbl1 (Rattus norvegicus - Norway rat)
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 5 156,601,986 - 156,613,182 (-) NCBI GRCr8 mRatBN7.2 5 151,318,752 - 151,329,948 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 5 151,318,754 - 151,338,719 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 5 154,015,980 - 154,027,177 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 5 155,790,290 - 155,801,487 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 5 155,772,293 - 155,783,465 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 5 157,524,569 - 157,535,701 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 5 157,524,513 - 157,535,664 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 5 161,263,765 - 161,274,897 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 Celera 5 149,703,598 - 149,714,771 (-) NCBI Celera Cytogenetic Map 5 q36 NCBI
NBL1 (Homo sapiens - human)
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 1 19,643,229 - 19,658,452 (+) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 1 19,596,979 - 19,658,456 (+) Ensembl GRCh38 hg38 GRCh38 GRCh37 1 19,969,723 - 19,984,945 (+) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 1 19,842,313 - 19,857,532 (+) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 1 19,715,031 - 19,730,251 NCBI Celera 1 18,296,492 - 18,311,717 (+) NCBI Celera Cytogenetic Map 1 p36.13 NCBI HuRef 1 18,215,821 - 18,231,031 (+) NCBI HuRef CHM1_1 1 20,078,997 - 20,094,228 (+) NCBI CHM1_1 T2T-CHM13v2.0 1 19,466,606 - 19,481,830 (+) NCBI T2T-CHM13v2.0
Nbl1 (Mus musculus - house mouse)
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 4 138,809,602 - 138,820,437 (-) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 4 138,809,595 - 138,820,304 (-) Ensembl GRCm39 Ensembl GRCm38 4 139,082,291 - 139,093,126 (-) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 4 139,082,284 - 139,092,993 (-) Ensembl GRCm38 mm10 GRCm38 MGSCv37 4 138,638,207 - 138,648,885 (-) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 4 138,354,368 - 138,364,941 (-) NCBI MGSCv36 mm8 Celera 4 140,868,231 - 140,871,576 (-) NCBI Celera Cytogenetic Map 4 D3 NCBI cM Map 4 70.57 NCBI
Nbl1 (Chinchilla lanigera - long-tailed chinchilla)
Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955452 308,573 - 319,989 (+) Ensembl ChiLan1.0 ChiLan1.0 NW_004955452 316,867 - 319,883 (+) NCBI ChiLan1.0 ChiLan1.0
NBL1 (Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 1 207,460,724 - 207,474,909 (-) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 1 206,577,562 - 206,591,747 (-) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 1 18,599,121 - 18,613,305 (+) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 1 19,652,853 - 19,656,431 (+) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 1 19,641,279 - 19,656,431 (+) Ensembl panpan1.1 panPan2
NBL1 (Canis lupus familiaris - dog)
Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 2 79,040,206 - 79,102,792 (-) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 2 79,041,105 - 79,102,820 (-) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 2 75,554,895 - 75,582,497 (-) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 2 79,607,161 - 79,634,902 (-) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 2 79,608,223 - 79,610,312 (-) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 2 76,425,235 - 76,452,808 (-) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 2 77,434,195 - 77,461,836 (-) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 2 78,503,885 - 78,531,526 (-) NCBI UU_Cfam_GSD_1.0
Nbl1 (Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl HiC_Itri_2 NW_024405058 39,996,034 - 40,018,509 (+) NCBI HiC_Itri_2 SpeTri2.0 Ensembl NW_004936474 5,840,240 - 5,859,749 (+) Ensembl SpeTri2.0 SpeTri2.0 Ensembl SpeTri2.0 NW_004936474 5,820,798 - 5,843,291 (+) NCBI SpeTri2.0 SpeTri2.0 SpeTri2.0
NBL1 (Sus scrofa - pig)
Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 6 78,059,392 - 78,071,604 (+) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 6 78,046,084 - 78,071,609 (+) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 6 72,138,765 - 72,142,022 (+) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
NBL1 (Chlorocebus sabaeus - green monkey)
Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 20 112,893,928 - 112,908,041 (-) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 20 112,893,633 - 112,897,355 (-) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666033 3,253,483 - 3,267,595 (+) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
Nbl1 (Heterocephalus glaber - naked mole-rat)
.
Predicted Target Of
Count of predictions: 138 Count of miRNA genes: 99 Interacting mature miRNAs: 114 Transcripts: ENSRNOT00000072299 Prediction methods: Miranda, Rnahybrid, Targetscan Result types: miRGate_prediction
10053720 Scort26 Serum corticosterone level QTL 26 2.06 0.0147 blood corticosterone amount (VT:0005345) plasma corticosterone level (CMO:0001173) 5 124965598 166875058 Rat 8552960 Pigfal15 Plasma insulin-like growth factor 1 level QTL 15 blood insulin-like growth factor amount (VT:0010479) plasma insulin-like growth factor 1 level (CMO:0001299) 5 111416838 156416838 Rat 2302369 Scl60 Serum cholesterol level QTL 60 3.13 blood cholesterol amount (VT:0000180) serum total cholesterol level (CMO:0000363) 5 143608201 161165651 Rat 631562 Apr2 Acute phase response QTL 2 3.7 blood murinoglobulin 1 amount (VT:0010597) plasma murinoglobulin 1 level (CMO:0001931) 5 135927956 166875058 Rat 61444 Strs2 Sensitivity to stroke QTL 2 4.7 cerebrum integrity trait (VT:0010549) post-insult time to onset of cerebrovascular lesion (CMO:0002343) 5 135929696 166875058 Rat 1300119 Bp180 Blood pressure QTL 180 3.82 arterial blood pressure trait (VT:2000000) blood pressure time series experimental set point of the baroreceptor response (CMO:0002593) 5 144358090 157869054 Rat 8552908 Pigfal4 Plasma insulin-like growth factor 1 level QTL 4 6.6 blood insulin-like growth factor amount (VT:0010479) plasma insulin-like growth factor 1 level (CMO:0001299) 5 128506074 166875058 Rat 61393 Bp7 Blood pressure QTL 7 4.5 0.0001 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 5 60293434 161481680 Rat 7794791 Mcs33 Mammary carcinoma susceptibility QTL 33 1.93 mammary gland integrity trait (VT:0010552) mammary tumor incidence/prevalence measurement (CMO:0000946) 5 131345754 166875058 Rat 7207486 Bss109 Bone structure and strength QTL 109 femur strength trait (VT:0010010) femur total energy absorbed before break (CMO:0001677) 5 106906205 151906205 Rat 1354631 Swd2 Spike wave discharge measurement QTL 2 3.64 0.0002 brain electrophysiology trait (VT:0010557) brain total spike-and-wave discharge duration (CMO:0001740) 5 151113452 164465185 Rat 7207481 Bss106 Bone structure and strength QTL 106 7.9 femur strength trait (VT:0010010) femur ultimate force (CMO:0001675) 5 106906205 151906205 Rat 1302790 Scl20 Serum cholesterol level QTL 20 6.4 0.0001 blood cholesterol amount (VT:0000180) plasma total cholesterol level (CMO:0000585) 5 82394392 166664054 Rat 1598861 Cm64 Cardiac mass QTL 64 2.9 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 5 127798274 166875058 Rat 1578766 Tcas11 Tongue tumor susceptibility QTL 11 4.12 tongue integrity trait (VT:0010553) number of squamous cell tumors of the tongue with diameter greater than 3 mm (CMO:0001950) 5 46711509 161317411 Rat 631263 Cm24 Cardiac mass QTL 24 3.5 heart mass (VT:0007028) heart left ventricle weight to body weight ratio (CMO:0000530) 5 143799107 158428037 Rat 631505 Bp103 Blood pressure QTL 103 3.2 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 5 132717196 165560427 Rat 1549838 Bss4 Bone structure and strength QTL 4 9.2 femur strength trait (VT:0010010) femur midshaft polar moment of inertia (CMO:0001669) 5 106906205 151906205 Rat 1641920 Colcs1 Colorectal carcinoma susceptibility QTL 1 2.99 0.0055 intestine integrity trait (VT:0010554) benign colorectal tumor surface area measurement (CMO:0001799) 5 121846814 166846814 Rat 8694169 Bw148 Body weight QTL 148 5 0.001 body mass (VT:0001259) body weight gain (CMO:0000420) 5 128506074 166875058 Rat 1331721 Bp210 Blood pressure QTL 210 3.413 arterial blood pressure trait (VT:2000000) blood pressure time series experimental set point of the baroreceptor response (CMO:0002593) 5 143069996 166846814 Rat 8657050 Bw146 Body weight QTL 146 19.84 0.001 body mass (VT:0001259) body weight gain (CMO:0000420) 5 108938288 153938288 Rat 631272 Lanf1 Left ventricular atrial natriuretic factor QTL 1 12 heart left ventricle natriuretic peptide A amount (VT:0010596) heart left ventricle natriuretic peptide A level (CMO:0002165) 5 151113452 166875058 Rat 1576314 Eutr1 Estrogen induced uterine response QTL 1 uterus integrity trait (VT:0010575) pyometritis severity score (CMO:0002009) 5 2138965 166875058 Rat 634349 Bp139 Blood pressure QTL 139 0.001 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 5 128924607 166875058 Rat 724525 Bp147 Blood pressure QTL 147 4.3 0.0001 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 5 126424772 166875058 Rat 1598847 Cm62 Cardiac mass QTL 62 3.4 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 5 108845856 153845856 Rat 738018 Anxrr4 Anxiety related response QTL 4 5.1 exploratory behavior trait (VT:0010471) percentage of entries into a discrete space in an experimental apparatus (CMO:0000961) 5 130130159 166875058 Rat 2313096 Bmd78 Bone mineral density QTL 78 3.1 0.0001 tibia mineral mass (VT:1000283) total volumetric bone mineral density (CMO:0001728) 5 144377876 161317411 Rat 7207488 Bss110 Bone structure and strength QTL 1 8.4 femur strength trait (VT:0010010) femur stiffness (CMO:0001674) 5 106906205 151906205 Rat 8694441 Bw169 Body weight QTL 169 17.61 0.001 retroperitoneal fat pad mass (VT:0010430) retroperitoneal fat pad weight to body weight ratio (CMO:0000635) 5 111416838 156416838 Rat 7207491 Bss112 Bone structure and strength QTL 112 7 femur morphology trait (VT:0000559) femur midshaft cortical cross-sectional area (CMO:0001663) 5 106906205 151906205 Rat 8694389 Bw160 Body weight QTL 160 6.17 0.001 body lean mass (VT:0010483) lean tissue morphological measurement (CMO:0002184) 5 111416838 156416838 Rat 8694198 Abfw3 Abdominal fat weight QTL 3 16.13 0.001 visceral adipose mass (VT:0010063) abdominal fat pad weight to body weight ratio (CMO:0000095) 5 111416838 156416838 Rat 1298090 Bp155 Blood pressure QTL 155 3.8 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 5 151006154 161165494 Rat 1298089 Scl14 Serum cholesterol level QTL 14 5.8 0.0004 blood cholesterol amount (VT:0000180) plasma total cholesterol level (CMO:0000585) 5 108845856 153845856 Rat 1598819 Bp292 Blood pressure QTL 292 4.3 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 5 127798274 166875058 Rat
AA963347
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 5 151,318,773 - 151,318,925 (+) MAPPER mRatBN7.2 Rnor_6.0 5 157,524,591 - 157,524,742 NCBI Rnor6.0 Rnor_5.0 5 161,263,787 - 161,263,938 UniSTS Rnor5.0 Celera 5 149,703,620 - 149,703,771 UniSTS RH 3.4 Map 5 1032.4 UniSTS Cytogenetic Map 5 q36.13 UniSTS
AU047985
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 5 151,326,895 - 151,327,192 (+) MAPPER mRatBN7.2 Rnor_6.0 5 157,532,649 - 157,532,945 NCBI Rnor6.0 Rnor_5.0 5 161,271,845 - 161,272,141 UniSTS Rnor5.0 Cytogenetic Map 5 q36.13 UniSTS
UniSTS:224311
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 5 151,319,532 - 151,319,694 (+) MAPPER mRatBN7.2 Rnor_6.0 5 157,525,350 - 157,525,511 NCBI Rnor6.0 Rnor_5.0 5 161,264,546 - 161,264,707 UniSTS Rnor5.0 Celera 5 149,704,379 - 149,704,540 UniSTS Cytogenetic Map 5 q36.13 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
9
11
49
113
91
90
59
25
59
6
218
97
93
45
60
31
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000072299 ⟹ ENSRNOP00000064345
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 5 151,318,754 - 151,329,948 (-) Ensembl Rnor_6.0 Ensembl 5 157,524,513 - 157,535,664 (-) Ensembl
Ensembl Acc Id:
ENSRNOT00000101272 ⟹ ENSRNOP00000079581
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 5 151,318,754 - 151,338,719 (-) Ensembl
RefSeq Acc Id:
NM_031609 ⟹ NP_113797
RefSeq Status:
PROVISIONAL
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 5 156,601,986 - 156,613,182 (-) NCBI mRatBN7.2 5 151,318,752 - 151,329,948 (-) NCBI Rnor_6.0 5 157,524,569 - 157,535,701 (-) NCBI Rnor_5.0 5 161,263,765 - 161,274,897 (-) NCBI Celera 5 149,703,598 - 149,714,771 (-) RGD
Sequence:
GCGCCTCGCCCCGCCCGGGGCCGCAGACGGCCAGCAGCGACAGACAGCCGAGCCTCGCGGGGCCGTCCCAGCCCGAGGACCCCGGGCCTGCGACCCCCGCGGCTCGCATCCCACTTTCTAAGACCTCT AAGAGGACGCGCCGGCCTCTTCGCGGCCACCGCGCGCGTTCCAGGGCTCCGGAGGTGACAGGCACAATGCTTTGGGTCCTGGTGGGGACTGTTCTCCCTGTCATGTTGCTGGCTGCCCCACCACCCAT CAACAAGCTGGCCCTGTTTCCGGACAAGAGTGCCTGGTGCGAAGCCAAGAACATCACGCAGATTGTGGGCCACAGCGGCTGTGAGGCCAAGTCTATCCAGAACAGGGCGTGCCTAGGACAATGCTTCA GTTACAGCGTCCCCAACACCTTCCCGCAGTCCACAGAGTCCCTGGTGCACTGTGACTCCTGCATGCCGGCCCAGTCCATGTGGGAGATTGTGACCTTGGAGTGCCCCGGCCACGAGGAGGTGCCCAGG GTGGACAAGCTGGTTGAGAAGATTGTACACTGCAGCTGCCAAGCCTGCGGCAAGGAACCCAGTCATGAGGGCCTGAACGTCTACATGCAGGGTGAAGATGGGCCAGGCTCCCAGCCAGGATCGCACTC CCACTCCCATCCCCACCCTGGGTGCCAGACCCCTGAACCTGAAGAACCTCCTGGAGCCCCTCAAGTTGAGGAAGAGGGGGCTGAGGACTGAGGGCCCCCAACTCTTCCTCCCCTCTTGTCCCCTGTGG AATGTCTGGTCCCACCCTCCAGGGAAGAGGGAGGGGAGAGGCAGAGGCCCCCCTCCCCCTCTGGCACTAGATGGACTTGGAATGTTGCCTGGTTGCCATGGAGATCTGAAGGGAGGGGCTGGAGCCAA GCTGCACGATTTAATATATGCAAGATGAGGGGAGGAAGCAGACATCTTTGGGACTTTTCTTTTGGAAGGTGAAGTGTGGTCTTTCCTTTCAGCCTTCTGGAGAGGAGCCCTCTGGATAGAGAGGAAGC AGGTTGAGCTGCTGAGGATGACTGAGATCCTCAGATAGGGCAGGCCCAGGTCAGGACCCAGACAACGGATGGGGCAGGATCCCCAGTGACGGGCAGAGGGTGGGTATCATGTCAGCATCCCCTTTGCA GGAGGATCTAGGTAGGAAGACAGCTGGCAGAAGTCGGAAACTCCAGCCCCATAGGTTTCCCTAAAGGCCTCCCCTCATGTAACCCCTTCAATGGAGTGGCTTAGGAGTCAGGCTGGGGCAGGACCCTG CTGACTCAGGTGCCAGAGTGTCACTGAAGAAGAAAGAAGATCCCTCTCCCCCACACCCTGTCCCTCCCTCCAGAGATCTTAGCTCTTTGCTCTCCCCAAGTTCTGGACTCTTCTGAAAACAGCTGCAA CCGGTCCTGCCGTCCTTGGGGCTGGTCTTTCTGAAAGAGGTGACAGTTTATCCCCATCACCTGGGACCGTAGTGGACAGGAGGCCCCTGCCTAGGGCCCCTGCTGACCTCAGCTTTCTCTAGCTCCTT ATTCTATCCACTCCTTCTTCCCAGCTGCACTTTAACCTTAGGGCAGGGCAGGTGGCGAGGAAGGGCCCTCTGTCTCCTTATCTGCTGGCACCATTGTGTCCAGGGGGTTGCCAGCTCACCCCCTCCCT GGGGGTGCCCCAGCCCATGGCTGTTTGACGAGAGCCTTAGAGCTTGTAACTAGTAGCCATCTCCCCTGAACCTGAGTGTTTCCATGAATAAAATGCCTTCAACGCCTCTACAAAAAAAAAAAAA
hide sequence
RefSeq Acc Id:
NP_113797 ⟸ NM_031609
- Peptide Label:
precursor
- UniProtKB:
Q6P750 (UniProtKB/Swiss-Prot), Q06880 (UniProtKB/Swiss-Prot), A0A0G2JSZ3 (UniProtKB/TrEMBL), A6ITK2 (UniProtKB/TrEMBL)
- Sequence:
MLWVLVGTVLPVMLLAAPPPINKLALFPDKSAWCEAKNITQIVGHSGCEAKSIQNRACLGQCFSYSVPNTFPQSTESLVHCDSCMPAQSMWEIVTLECPGHEEVPRVDKLVEKIVHCSCQACGKEPSH EGLNVYMQGEDGPGSQPGSHSHSHPHPGCQTPEPEEPPGAPQVEEEGAED
hide sequence
Ensembl Acc Id:
ENSRNOP00000064345 ⟸ ENSRNOT00000072299
Ensembl Acc Id:
ENSRNOP00000079581 ⟸ ENSRNOT00000101272
RGD ID: 13694199
Promoter ID: EPDNEW_R4724
Type: multiple initiation site
Name: Nbl1_1
Description: neuroblastoma 1, DAN family BMP antagonist
SO ACC ID: SO:0000170
Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ )
Experiment Methods: Single-end sequencing.
Position: Rat Assembly Chr Position (strand) Source Rnor_6.0 5 157,535,676 - 157,535,736 EPDNEW
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2018-05-18
Nbl1
NBL1, DAN family BMP antagonist
Nbl1
neuroblastoma 1, DAN family BMP antagonist
Nomenclature updated to reflect human and mouse nomenclature
1299863
APPROVED
2013-03-07
Nbl1
neuroblastoma 1, DAN family BMP antagonist
Nbl1
neuroblastoma 1
Nomenclature updated to reflect human and mouse nomenclature
1299863
APPROVED
2013-03-06
Nbl1
neuroblastoma 1
Nbl1
neuroblastoma, suppression of tumorigenicity 1
Nomenclature updated to reflect human and mouse nomenclature
1299863
APPROVED
2004-02-26
Nbl1
neuroblastoma, suppression of tumorigenicity 1
neuroblastoma, suppression of tumorigenicity 1
Symbol and Name status set to approved
625702
APPROVED
2002-06-10
Nbl1
neuroblastoma, suppression of tumorigenicity 1
Name updated
70585
PROVISIONAL
Note Type
Note
Reference
gene_domains
contains a putative zinc-finger domain and a proline-rich domain
729039
gene_protein
178 amino acid residues
729039